Prime CAR-T cell (CD19/CD22-targeted)

CD19 and CD22 targeted Prime CAR-T cell · Chongqing Precision Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Prime CAR-T cell (CD19/CD22-targeted), covering 2025-02-25 to 2025-02-25. Get the full timeline:

Most recent: Clinical Trial Update: a Clinical Research of CD19 and CD22 Targeted Prime CAR-T Cell in Relapsed/Refractory B-ALL [Phase 1, Phase 2]